IL6 and syringocystadenoma papilliferum: In our study, IL-6 showed a trend of gradual upregulation with pneumonia severity, it was a selected feature for discrimination between uCAP and sCAP and correlated with the plasma levels of IL-8, which has been described to be significantly higher in sCAP patients compared to milder CAP (30).